Below is a condensed transcript of that exchange, in which Kennedy and Sanders spoke over each other and repeated themselves: ...

In the rapidly evolving digital era, the pharmaceutical industry faces significant cybersecurity challenges, where data ...

The industry is grappling with significant market shifts amidst emerging technologies and changing demands. Companies are now ...

Top Republican recipients of contributions from employees or PACS associated with the pharmaceutical/health products ...

Topline data on a combo including Pfizer’s kinase inhibitor Braftovi point to improved progression-free survival and pave the ...

Refractory chronic cough represents a significant unmet need with no FDA-approved treatment options and $11B total addressable global market ...

rising at a CAGR of 10.15% The global pharmaceutical R&D outsourcing market report consists of exclusive data on 44 vendors. Major players like Boehringer Ingelheim, Charles River Laboratories, ICON, ...

Analyst is bullish on Vertex Pharmaceuticals, citing FDA approval for JOURNAVX and strong earnings growth potential in 2025.

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

Madrigal Pharmaceuticals (MDGL – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Yasmeen ...

Ultragenyx Pharmaceutical is a mid-cap biotech firm with a promising pipeline and an optimistic outlook from analysts. Click ...